What medications should be used to treat acute agitation and aggression, including rapid‑acting agents and subsequent oral maintenance therapy?

Medications for Acute Agitation and Aggression

For acute agitation in the emergency department, use either a benzodiazepine (lorazepam 2-4 mg or midazolam 2.5-5 mg) or an antipsychotic (haloperidol 5 mg, droperidol 5 mg, or ziprasidone 20 mg IM) as effective first-line monotherapy, with oral formulations preferred when patients are cooperative. 1

Rapid-Acting Agents for Acute Management

First-Line Options

Oral medications (when patient is cooperative):

• Lorazepam 0.5-1 mg (up to 4 mg/24 hours; reduce to 0.25-0.5 mg in elderly, max 2 mg/24 hours) 2
• Olanzapine + Lorazepam combination shows superior efficacy in cooperative patients 3
• Oral formulations achieve adequate sedation in 15 minutes, equivalent to IM routes 3

Intramuscular medications (when oral route not feasible):

• Ziprasidone 20 mg IM: Most effective dose with rapid onset (30 minutes), notably absent of extrapyramidal symptoms, better tolerated than haloperidol 1, 4
• Haloperidol 5 mg IM: Strongest evidence base among conventional antipsychotics, though higher risk of extrapyramidal symptoms 1
• Lorazepam 2-4 mg IM: At least as effective as haloperidol with fewer side effects 1
• Droperidol 5 mg IV/IM: Faster sedation than haloperidol, fewer repeat doses needed, shorter ED length of stay—despite FDA black box warning, large series show safety in patients without serious comorbidities 1
• Midazolam 2.5-5 mg SC: Rapid sedation but poses excessive risk in older adults (5.25 times higher adverse events vs haloperidol) 2, 5

Combination Therapy

Haloperidol 5 mg + Lorazepam 2 mg may produce more rapid sedation than monotherapy, though evidence is Level C 1. The combination shows significantly greater decrease in agitation at 1 hour compared to either agent alone 1.

Critical Safety Considerations

Avoid in Specific Contexts

Anticholinergic or sympathomimetic intoxication: Antipsychotics can exacerbate agitation due to anticholinergic side effects—benzodiazepines preferred 1

Older adults: Midazolam carries excessive risk (53% adverse event rate); quetiapine shows lowest adverse event profile (OR 0.27 vs haloperidol) 5. For elderly with dementia, use lowest effective doses and only when dangerous agitation/psychosis present 6, 7.

Monitoring Requirements

• QTc prolongation: All antipsychotics prolong QTc at maximum doses, though none exceed 500 ms in studies. Ziprasidone has relatively greater propensity—avoid in patients with known QTc conditions 1, 4
• Respiratory depression: Particularly with benzodiazepines and combination therapy 5
• Extrapyramidal symptoms: Haloperidol 11 times more likely than lorazepam; ziprasidone and atypical antipsychotics have lower rates 1

Subsequent Oral Maintenance Therapy

Transition Strategy

Transition to oral formulation of the same agent used for acute management once agitation diminishes 8, 4. This approach has been validated in double-blind trials for haloperidol, olanzapine, ziprasidone, and aripiprazole.

Maintenance Options by Underlying Condition

For psychotic disorders:

• Atypical antipsychotics (risperidone 0.25 mg daily titrated to 2-3 mg; olanzapine 2.5 mg daily titrated to 10 mg; quetiapine 12.5 mg BID titrated to 200 mg BID) 6
• Atypical agents have diminished risk of extrapyramidal symptoms and tardive dyskinesia compared to typical antipsychotics 6

For dementia-related agitation:

• Use antipsychotics judiciously—benefits are small in trials, but appropriate for dangerous agitation 7
• Start with lowest doses: risperidone 0.25 mg daily, olanzapine 2.5 mg daily 6
• Consider mood stabilizers as alternatives: trazodone 25 mg daily (titrate to 200-400 mg), divalproex 125 mg BID (better tolerated than carbamazepine) 6

For anxiety-predominant agitation:

• Lorazepam for short-term use (risk of tolerance, addiction, cognitive impairment with regular use) 6
• Buspirone 5 mg BID (titrate to 20 mg TID) for mild-moderate agitation—takes 2-4 weeks to become effective 6

Algorithmic Approach

1. Attempt verbal de-escalation first—proceed to medication only when behavioral management fails 1

2. Identify reversible causes: hypoxia, urinary retention, constipation, drug intoxication 2

3. Route selection:

   • Cooperative patient → Oral lorazepam or olanzapine 3
   • Uncooperative/severe agitation → IM ziprasidone 20 mg (best tolerability) or IM haloperidol 5 mg (strongest evidence) 1
   • Avoid midazolam in elderly 5

4. Reassess at 30-60 minutes; consider repeat dosing or combination therapy if inadequate response 1

5. Transition to oral maintenance with same agent once acute episode controlled 8, 4